Cannabidiol for at risk for psychosis youth: A randomized controlled trial

No biological treatment has been firmly established for the at-risk stage of psychotic disorder. In this study we aim to test if subthreshold psychotic symptoms can be effectively treated with cannabidiol (CBD), a non-psychoactive compound of the plant Cannabis sativa.

Citation:
Amminger GP, Lin A, Kerr M, Weller A, Spark J, Pugh C, et al. Cannabidiol for at risk for psychosis youth: A randomized controlled trial. Early Intervent Psychiatry. 2021.

Keywords:
RCT; cannabidiol; psychosis; ultra-high risk; youth

Abstract:
No biological treatment has been firmly established for the at-risk stage of psychotic disorder. In this study we aim to test if subthreshold psychotic symptoms can be effectively treated with cannabidiol (CBD), a non-psychoactive compound of the plant Cannabis sativa.